CAMBRIDGE, Mass.--(BUSINESS WIRE)--Verastem, Inc. (NASDAQ:VSTM), focused on discovering and developing drugs to treat cancer by the targeted killing of cancer stem cells, announced that the Company will present at upcoming investor conferences. The presentation details are as follows:
- 26th Annual Roth Conference on Monday, March 10th at 11:30 a.m. PT at The Ritz Carlton in Dana Point, CA
- Barclays Capital Global Healthcare Conference on Tuesday, March 11th at 3:15 p.m. ET at the Loews Miami Hotel in Miami, FL
Webcasts of the presentations can be accessed by visiting the investors section of the Company’s website at www.verastem.com. Replays of each of the webcasts will be archived on the Verastem website for 90 days following the presentation dates.
About Verastem, Inc.
Verastem, Inc. (NASDAQ:VSTM) is discovering and developing drugs to treat cancer by the targeted killing of cancer stem cells. Cancer stem cells are an underlying cause of tumor recurrence and metastasis. Verastem is developing small molecule inhibitors of signaling pathways that are critical to cancer stem cell survival and proliferation: FAK, PI3K/mTOR and Wnt. For more information, please visit www.verastem.com.
Any statements in this press release about future expectations, plans and prospects for the Company constitute forward-looking statements within the meaning of The Private Securities Litigation Reform Act of 1995. Actual results may differ materially from those indicated by such forward-looking statements. The Company anticipates that subsequent events and developments will cause the Company’s views to change. However, while the Company may elect to update these forward-looking statements at some point in the future, the Company specifically disclaims any obligation to do so.